Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry

Trial ID or NCT#

NCT01144780

Status

not recruiting iconNOT RECRUITING

Purpose

The objective of this study is to better understand the underlying pathogenetic mechanisms of myeloproliferative disorders (MPDs). We will collect peripheral blood samples from MPD patients and utilize multiparameter phospho-specific flow cytometry to investigate dysregulated signaling in blood cells from these patients. This will provide deeper insights into the pathogenesis of MPDs and may lead to the identification of novel targets for therapeutic intervention.

Official Title

Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. Any patient who carries a diagnosis of a myeloproliferative disorder (MPD).
Exclusion Criteria:
  1. Any patient who is not willing to give consent.

Investigator(s)

Jason Gotlib
Hematologist-Oncologist
Professor of Medicine (Hematology)

Contact us to find out if this trial is right for you.

Contact

Stephen Oh
650-723-7875